Bipolar Disorder Sitemap

Bipolar Disorder News:

AstraZeneca receives approval for bipolar drug - The Associated Press

AstraZeneca receives approval for bipolar drug
The Associated Press - Nov 13, 2008
LONDON (AP) EUR” Pharmaceutical company AstraZeneca PLC said Thursday European regulators have approved a new version of its bipolar disorder drug Seroquel. .
Seroquel and Seroquel XR approved for new indications in bipolar . Scrip World Pharmaceutical News (subscription)
AstraZeneca´s Seroquel, Seroquel XR Gets Approval In Europe For . Network MÃdica
UPDATE: AstraZeneca Seroquel Gets EU OK For Bipolar Disorder EasyBourse.com
Reuters - RTT News
all 93 news articles

Astra's bipolar drug gets European approval (ShareCast)
LONDON (SHARECAST) - Anglo-Swedish drug giant AstraZenecas Seroquel and Seroquel XR drugs have been approved in Europe for the treatment of major depressive episodes in bipolar disorder...

SEROQUEL XR„¢ And SEROQUEL(R) Approved In Europe For New Indications For The Treatment Of Bipolar Disorder (Medical News Today)
AstraZeneca today announced that the once-daily formulation SEROQUEL XR„¢ (quetiapine fumarate extended release tablets) and SEROQUEL (quetiapine fumarate) have been approved via the Mutual Recognition Procedure for new indications in bipolar disorder. SEROQUEL XR and SEROQUEL have been approved for treatment of major depressive episodes in bipolar disorder...

AstraZeneca receives approval for bipolar drug (San Francisco Chronicle)
Pharmaceutical company AstraZeneca PLC said Thursday European regulators have approved a new version of its bipolar disorder drug Seroquel. The drug company said a once-daily formulation, Seroquel XR, has been approved by the European Mutual Recognition...

AstraZeneca receives approval for bipolar drug (AP via Yahoo! News)
Pharmaceutical company AstraZeneca PLC said Thursday European regulators have approved a new version of its bipolar disorder drug Seroquel...

Bi-polar trek to raise awareness - Stuff.co.nz

Bi-polar trek to raise awareness
Stuff.co.nz, New Zealand - Nov 14, 2008
"Bipolar disorder is more debilitating than most mental disorders and usually goes undiagnosed for far too long," Monasterio said. .

Psychotherapy for bipolar disorder
Despite advances in drug treatment most people with bipolar disorder cannot be treated with medication alone. Up to 50% of bipolar patients do not recover from acute manic episodes within a year and only 25% achieve full recovery of ...

Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar . - MarketWatch

Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar .
MarketWatch - Nov 6, 2008
"Episodes of depression are the most frequent and long-lived symptom of bipolar disorder and account for the majority of the disease impairment. .

AstraZeneca's Seroquel wins European approval for new indications (Pharmaceutical Business Review)
UK-based healthcare company AstraZeneca has announced that the once-daily formulation Seroquel XR and Seroquel have received approval under the European mutual recognition procedure for new indications in bipolar disorder...

Bipolar Disorder Help